Evercore ISI upgraded shares of Icon PLC (NASDAQ:ICLR) from a hold rating to a buy rating in a research report released on Friday. The firm currently has $89.00 price objective on the stock, up from their prior price objective of $81.50.
Several other equities research analysts have also issued reports on the stock. Credit Suisse Group AG initiated coverage on shares of Icon PLC in a report on Monday, June 20th. They set an outperform rating and a $80.00 price target on the stock. Robert W. Baird reaffirmed an outperform rating and set a $83.00 price target on shares of Icon PLC in a report on Monday, June 27th. KeyCorp reaffirmed a buy rating and set a $85.00 price target on shares of Icon PLC in a report on Wednesday, July 27th. Jefferies Group lifted their price target on shares of Icon PLC from $78.00 to $80.00 and gave the company a hold rating in a report on Wednesday, July 27th. Finally, Zacks Investment Research raised shares of Icon PLC from a hold rating to a buy rating and set a $87.00 price target on the stock in a report on Wednesday, September 28th. One research analyst has rated the stock with a sell rating, two have given a hold rating and six have given a buy rating to the company. The company currently has a consensus rating of Buy and an average target price of $80.25.
Icon PLC (NASDAQ:ICLR) opened at 78.94 on Friday. Icon PLC has a one year low of $62.31 and a one year high of $79.80. The company has a 50-day moving average of $76.78 and a 200 day moving average of $72.36. The firm has a market capitalization of $4.38 billion, a price-to-earnings ratio of 18.25 and a beta of 0.66.
Icon PLC (NASDAQ:ICLR) last announced its quarterly earnings results on Tuesday, July 26th. The company reported $1.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.14. The company had revenue of $411 million for the quarter, compared to analyst estimates of $409.97 million. Icon PLC had a net margin of 15.70% and a return on equity of 29.89%. The firm’s revenue was up 5.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.95 EPS. On average, analysts anticipate that Icon PLC will post $4.70 EPS for the current year.
A number of large investors have recently bought and sold shares of ICLR. Societe Generale acquired a new stake in Icon PLC during the second quarter valued at approximately $129,000. SG Americas Securities LLC acquired a new stake in Icon PLC during the second quarter valued at approximately $129,000. Invictus RG increased its stake in Icon PLC by 2.2% in the second quarter. Invictus RG now owns 1,852 shares of the company’s stock valued at $130,000 after buying an additional 40 shares in the last quarter. Creative Planning increased its stake in Icon PLC by 91.1% in the second quarter. Creative Planning now owns 2,073 shares of the company’s stock valued at $145,000 after buying an additional 988 shares in the last quarter. Finally, J.Safra Asset Management Corp acquired a new stake in Icon PLC during the second quarter valued at approximately $150,000. Institutional investors and hedge funds own 93.73% of the company’s stock.
About Icon PLC
ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies.
Receive News & Ratings for Icon PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon PLC and related companies with MarketBeat.com's FREE daily email newsletter.